Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Devic's Disease”

173 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 173 results

Not applicableEnrolling By InvitationNCT06643858
What this trial is testing

Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)

Who this might be right for
HealthyMultiple SclerosisNeuromyelitis Optica Spectrum Disorders+2 more
Beijing Tiantan Hospital 10,000
Not applicableStudy completedNCT03121105
What this trial is testing

Pathologic-MRI Findings in Atypical IIDD

Who this might be right for
Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
University Hospital, Montpellier 25
Testing effectiveness (Phase 2)Looking for participantsNCT07184840
What this trial is testing

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital 110
Early research (Phase 1)WithdrawnNCT03605238
What this trial is testing

Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Chinese PLA General Hospital
Not applicableEnrolling By InvitationNCT06374264
What this trial is testing

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
MedRhythms, Inc. 30
Not applicableLooking for participantsNCT06280755
What this trial is testing

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more
icometrix 7,000
Not applicableLooking for participantsNCT06941584
What this trial is testing

Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies

Who this might be right for
AIRE Deficiency
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Not applicableUnknownNCT03370965
What this trial is testing

Optic Neuritis Differential Diagnosis Study

Who this might be right for
Optic NeuritisNeuromyelitis OpticaMultiple Sclerosis
University Hospital Center of Martinique 150
Not applicableActive Not RecruitingNCT06906692
What this trial is testing

Meningococcal Vaccination in Patients on Complement Inhibitors

Who this might be right for
Myasthenia Gravis GeneralisedVaccinationComplement System+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 35
Large-scale testing (Phase 3)Active Not RecruitingNCT05314010
What this trial is testing

MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Beijing Mabworks Biotech Co., Ltd. 102
Early research (Phase 1)Not Yet RecruitingNCT06633042
What this trial is testing

The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD

Who this might be right for
Autoimmune Disease
Bioray Laboratories 18
Not applicableLooking for participantsNCT06443333
What this trial is testing

National, Multicentric Registry Study on Neuroimmunological Diseases in China

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+3 more
Xuanwu Hospital, Beijing 7,000
Not applicableUnknownNCT05245344
What this trial is testing

Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)Neuromyelitis OpticaHealthy
Neuromed IRCCS 154
Not applicableLooking for participantsNCT06398158
What this trial is testing

Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica
University of Texas Southwestern Medical Center 35
Not applicableTemporarily pausedNCT07247292
What this trial is testing

Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia

Who this might be right for
Rare DiseasesNeuromyelitis Optica Spectrum Disorder (NMOSD)
AstraZeneca 100
Testing effectiveness (Phase 2)Study completedNCT05551598
What this trial is testing

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 46
Not applicableUnknownNCT05414487
What this trial is testing

Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisorderDemyelinating Diseases of the Central Nervous System
Tianjin Medical University General Hospital 34
Not applicableLooking for participantsNCT05566769
What this trial is testing

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

Who this might be right for
Neuromyelitis Optica
Ad scientiam 103
Not applicableUnknownNCT05284175
What this trial is testing

Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Peking Union Medical College Hospital 23
Large-scale testing (Phase 3)UnknownNCT00004645
What this trial is testing

Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone

Who this might be right for
Acute Disseminated EncephalomyelitisDevic's SyndromeMarburg's Variant of Multiple Sclerosis+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 22
Load More Results